After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has ...
Stifel Nicolaus analyst Rick Wise has maintained their bullish stance on MASI stock, giving a Buy rating yesterday.Stay Ahead of the ...
Masimo (MASI – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Vik Chopra from Wells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback